Renovos Biologics has appointed Patrick O’Donnell as Advisor to the Board
Previously a General Manager and Executive Vice-President of North America for BoneSupport A.B., CEO at Proteothera, Inc, Histogenics Corporation, Prochon-BioTech, and in commercial roles of escalating management responsibility at Confluent Surgical Inc. and J & J DePuy-Spine, Patrick has a wealth of experience in the medical device, biologics, and biomaterials industries with technologies in the orthopedic, spine, neurosurgery, sports medicine, interventional radiology markets.
As an executive officer of biosurgery and medical device companies, he has created the strategy, built and led the commercial organizations, and raised capital (over $80M) to fund and execute the product development and clinical programs towards regulatory milestones.
With a passion for outstanding technologies in the orthobiologics space, Patrick will contribute to Renovos’ strategy for nanoclay commercialisation.
It is exciting for Renovos to welcome someone with such experience and enthusiasm for our Renovite nanoclay technology and we are looking forward to not only working with Patrick but also to the advances we can make with his support.